Tyco/Nellcor will pay Masimo an ongoing royalty for the right to sell its new line of pulse oximetry products under a patent litigation settlement announced Jan. 23. All pending litigation between the market rivals is dismissed (1"The Gray Sheet" April 5, 2004, p. 26). Nellcor has paid Masimo $265 mil. for damages and $65 mil. in advanced royalties as of Jan. 31...

Tyco/Nellcor will pay Masimo an ongoing royalty for the right to sell its new line of pulse oximetry products under a patent litigation settlement announced Jan. 23. All pending litigation between the market rivals is dismissed (1"The Gray Sheet" April 5, 2004, p. 26). Nellcor has paid Masimo $265 mil. for damages and $65 mil. in advanced royalties as of Jan. 31...

California federal appeals court denies Tyco/Nellcor's appeals and places a permanent injunction on the affected Nellcor pulse oximetry products, according to Masimo. In March 2004, a Los Angeles federal court jury found that Nellcor had infringed Masimo's patents and subsequently awarded Masimo $134.5 mil. According to Masimo, that figure was increased to $164 mil. when Nellcor continued to infringe on its products through May 2004. Masimo claims that damages have accrued further since the final judgment. Nellcor is the pulse oximetry market leader, with Masimo holding a distant second place spot (1"The Gray Sheet" April 5, 2004, p. 26)...